SCHEMBL31060494

SCHEMBL31060494

COCCOc1ccc2c(c1)ncn2-c1ccc2cccc(N3CCC(N)CC3)c2n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.72
GAK O14976 1/20 0.72
RIPK2 O43353 1/20 0.72
ULK1 O75385 1/20 0.72
STK10 O94804 1/20 0.72
PRKD3 O94806 1/20 0.72
MAP4K4 O95819 1/20 0.72
LATS1 O95835 1/20 0.72
PAK4 O96013 1/20 0.72
NTRK1 P04629 1/20 0.72
LCK P06239 1/20 0.72
CDK1 P06493 1/20 0.72
APRT P07741 1/20 0.72
RET P07949 1/20 0.72
PDGFRB P09619 1/20 0.72
PHKG2 P15735 1/20 0.72
NQO2 P16083 1/20 0.72
PDGFRA P16234 1/20 0.72
FECH P22830 1/20 0.72
CDK2 P24941 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL859537 1.00 IRAK4 (0.72) IRAK4GAKRIPK2ULK1STK10
SCHEMBL29678517 1.00 IRAK4 (0.72) IRAK4GAKRIPK2ULK1STK10
SCHEMBL5766267 0.95 IRAK4 (0.66) IRAK4GAKRIPK2ULK1STK10
SCHEMBL5764297 0.95 IRAK4 (0.66) IRAK4GAKRIPK2ULK1STK10
SCHEMBL5766257 0.95 IRAK4 (0.66) IRAK4GAKRIPK2ULK1STK10
SCHEMBL5764257 0.91 IRAK4 (0.61) IRAK4GAKRIPK2ULK1STK10
SCHEMBL5764385 0.91 IRAK4 (0.61) IRAK4GAKRIPK2ULK1STK10
SCHEMBL5764259 0.90 IRAK4 (0.60) IRAK4GAKRIPK2ULK1STK10
SCHEMBL5763184 0.90 IRAK4 (0.71) IRAK4GAKRIPK2ULK1STK10
SCHEMBL5766337 0.90 IRAK4 (0.71) IRAK4GAKRIPK2ULK1STK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed
WO-2024151804-A2 METHODS AND MATERIALS FOR GENERATING STEM CELL-DERIVED ENDOCRINE CELL TYPES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2024-07-18 WO disclosed